Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Schöler

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Current Opinion in Gastroenterology|February 16, 2024
The role of the microbiome in liver diseaseDavid Schöler, Bernd Schnabl
Biological Chemistry|June 2, 2019
Tauroursodeoxycholate protects from glycochenodeoxycholate-induced gene expression changes in perfused rat liverMartha Paluschinski, Mirco Castoldi, David Schöler, et al.
Journal of Clinical Medicine|August 12, 2022
Machine Learning Can Predict the Probability of Biologic Therapy in Patients with Inflammatory Bowel DiseaseDavid Schöler, Karel Kostev, Maximilian Peters, et al.
Journal of Cancer Research and Clinical Oncology|July 22, 2022
Differential role of chronic liver diseases on the incidence of cancer: a longitudinal analysis among 248,224 outpatients in GermanySven H Loosen, David Schöler, Mark Luedde, et al.
Journal of Clinical Medicine|April 23, 2022
An Elevated FIB-4 Score Is Associated with an Increased Incidence of Depression among Outpatients in GermanyDavid Schöler, Karel Kostev, Münevver Demir, et al.
Plos One|January 23, 2024
Surgical and per-oral endoscopic myotomy (POEM) for the treatment of primary esophageal motility disorders: A systematic analysis of current trends in Germany between 2011 and 2019Jennis Kandler, Tobias Essing, David Schöler, et al.
Journal of Clinical Medicine|November 26, 2022
Antihypertensive Therapy and Incidence of CancerSven H Loosen, David Schöler, Mark Luedde, et al.
Cancers|August 12, 2022
The Spectrum of Co-Diagnoses in Patients with Colorectal Cancer: A Retrospective Cohort Study of 17,824 Outpatients in GermanySven H Loosen, David Schöler, Simon Labuhn, et al.
JHEP Reports : Innovation in Hepatology|March 15, 2022
Swelling-induced upregulation of miR-141-3p inhibits hepatocyte proliferationNils Bardeck, Martha Paluschinski, Mirco Castoldi, et al.
Plos One|August 18, 2021
Enlarged extracellular vesicles are a negative prognostic factor in patients undergoing TACE for primary or secondary liver cancer-a case seriesDavid Schöler, Mirco Castoldi, Markus S Jördens, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Current Opinion in Gastroenterology|February 16, 2024
The role of the microbiome in liver diseaseDavid Schöler, Bernd Schnabl
Biological Chemistry|June 2, 2019
Tauroursodeoxycholate protects from glycochenodeoxycholate-induced gene expression changes in perfused rat liverMartha Paluschinski, Mirco Castoldi, David Schöler, et al.
Journal of Clinical Medicine|August 12, 2022
Machine Learning Can Predict the Probability of Biologic Therapy in Patients with Inflammatory Bowel DiseaseDavid Schöler, Karel Kostev, Maximilian Peters, et al.
Journal of Cancer Research and Clinical Oncology|July 22, 2022
Differential role of chronic liver diseases on the incidence of cancer: a longitudinal analysis among 248,224 outpatients in GermanySven H Loosen, David Schöler, Mark Luedde, et al.
Journal of Clinical Medicine|April 23, 2022
An Elevated FIB-4 Score Is Associated with an Increased Incidence of Depression among Outpatients in GermanyDavid Schöler, Karel Kostev, Münevver Demir, et al.
Plos One|January 23, 2024
Surgical and per-oral endoscopic myotomy (POEM) for the treatment of primary esophageal motility disorders: A systematic analysis of current trends in Germany between 2011 and 2019Jennis Kandler, Tobias Essing, David Schöler, et al.
Journal of Clinical Medicine|November 26, 2022
Antihypertensive Therapy and Incidence of CancerSven H Loosen, David Schöler, Mark Luedde, et al.
Cancers|August 12, 2022
The Spectrum of Co-Diagnoses in Patients with Colorectal Cancer: A Retrospective Cohort Study of 17,824 Outpatients in GermanySven H Loosen, David Schöler, Simon Labuhn, et al.
JHEP Reports : Innovation in Hepatology|March 15, 2022
Swelling-induced upregulation of miR-141-3p inhibits hepatocyte proliferationNils Bardeck, Martha Paluschinski, Mirco Castoldi, et al.
Plos One|August 18, 2021
Enlarged extracellular vesicles are a negative prognostic factor in patients undergoing TACE for primary or secondary liver cancer-a case seriesDavid Schöler, Mirco Castoldi, Markus S Jördens, et al.
Pageof 2